Skip Navigation
Part B HomePart B HomePart B Home

IMPORTANT: THIS DOCUMENT CONTAINS OUTDATED INFORMATION.
Content provided on this page contains outdated information and instruction and should not be considered current. CGS is providing this archived information for research purposes only. This archived section contains previously issued instructions that have since been updated or are no longer applicable for Medicare billing purposes.

To view all current Part B Medicare news, articles, and information, please visit our Part B site.

Send this page to a colleague

August 28, 2008

CIGNA Medicare Part B Carrier for Idaho, North Carolina, and Tennessee Usually Self Administered Drug Report 08/21/2008

HCPCS Descriptor Effective Date of Exclusion End Date of Exclusion Comments
J0135 Adalimumab (Humira) (Effective 01/01/05 bill under J0135, previously billed under J3490 - no change to coverage) 09/21/2003 N/A Apparent on its face/USA/SC every other week
J0270 Alprostadil (Caverject, Prostaglandins, Muse) 01/01/1997 N/A Apparent on its face/USA/ Intracavernosal or Intraurethral/ Use as Needed
J0364 Apomorphine Hydrochloride (Apokyn) New code for 2007 01/01/2007 N/A Frequency/Apparent on its face/USA/ SC Daily
J3490 Becaplerim, a self-administered, non-autologous growth factor for chronic, nonhealing, subcutaneous wounds, is nationally non-covered. 04/27/2006 N/A Based on CMS National Coverage Decisions Manual 100-03 section 270.3.
J0630 Calcitonin Salmon 01/01/1982 N/A Frequency/Apparent on its face/USA/ SC as needed
J3490 Chorionic Gonadotropin Alfa, Recombinant (Ovidrel) 01/01/2008 N/A Administered SC by the patient, based on labeled instruction from manufacturer
J1324 Enfuvirtide (Fuzeon) New code for 2007 01/01/2007 N/A Frequency/Apparent on its face/USA/SC twice daily
J1438 Etanercept (Enbrel) 01/01/2003 N/A Apparent on its face/USA/SC twice a week
J1595 Glatiramer Acetate (Copaxone) (previously billed under code Q2010, this code has been deleted - no change to coverage) 01/01/2003 N/A Frequency/Apparent on its face/USA/ SC Daily
J1675 Histrelin Acetate (effective 01/01/06 use J1675 - previously billed under HCPCS Q2020 - no change to coverage) 01/01/2000 N/A Frequency/Apparent on its face/USA/ SC Daily
J1815 Insulin 01/01/2003 N/A Frequency/Apparent on its face/USA/ SC/Daily
J1817 Insulin 01/01/2003 N/A Frequency/Apparent on its face/USA/ SC/Daily
J3490 Kutapressin (previously billed under code J1910, this code has been deleted) 01/01/2003 N/A Frequency/USA/ SC or IM Daily
J9218 Leuprolide Acetate Injection - 1 mg. daily subcutaneous 01/01/1990 N/A Frequency/Apparent on its face/USA/ SC Daily
J2170 Mecasermin (Increlex or Iplex) New code for 2007 01/01/2007 N/A Frequency/Apparent on its face/USA/SC Daily
J3490 Pegvisomant for injection (Somavert) 07/20/2003 N/A Frequency/Apparent on its face/USA/SC Daily
J2940 Somatrem 01/01/2003 N/A Frequency/Apparent on its face/USA/ SC or IM Daily
J2941 Somatropin, Inj. (Genotropin, Humatrope, Norditropin, Nutropin AQ, Saizen, Serostim are all SC {Daily or 3 times weekly} and Nutropin Depot once monthly or twice monthly on same days {i.e., 1st & 15th}) 01/01/2003 N/A Apparent on its face/Frequency/USA/SC Daily/SC or IM 3 times weekly
J3030 Sumatriptan Succinate 01/01/1995 N/A Apparent on its face/USA/SC as needed
J3110 Teriparatide (Forteo) (effective 01/01/05 use J3110 - previously billed under HCPCS J3490 - no change to coverage) 07/20/2003 N/A Frequency/Apparent on its face/USA/SC Daily

Contractors must provide notice 45 days prior to the date a drug will be excluded/not covered. During the 45 day time period, contractors will maintain existing medical review and payment procedures. See our website http://www.cignagovernmentservices.com/partb/pubs/news/2002/1002/ws0351.html for more information on the determination process.

Comment Period: N/A Reviewed only no changes made as of 08/21/2008

Update Effective: 01/01/2008

An ISO 9001:2008 certified company

Home | Helpful Links | About Us | Careers | Site Map | Disclaimer | Contact Us


Centers for Medicare &  Medicaid Services